SEMA6B and testicular cancer: Recently, SEMA6B has been shown to exhibit higher expression levels in testicular cancer tissues than in normal tissues and is considered to be a predictor of poor prognosis in patients with testicular germ-cell tumors (Ji and Wang, 2020).